Most vulnerable often overlooked in clinical trials of new treatments for COVID-19
2021-02-03
(Press-News.org) Studies examining the effectiveness of treatments for COVID-19 often do not include the very populations hardest hit by the disease, according to a new review by University of Chicago Medicine researchers.
The findings, based on an analysis of all US COVID-19 treatment trials registered on ClinicalTrials.gov, were published Jan. 27 in the Journal of General Internal Medicine.
"This study highlights the blind spot in how clinical trials are done in the United States," said senior author Neda Laiteerapong, MD, MS, a general internist and associate director of the Center for Chronic Disease Research and Policy at the University of Chicago. "Researchers, hospitals and pharmaceutical companies need to think hard about their commitment to improving the health of all people."
Since the pandemic began, certain communities have been disproportionately affected by COVID-19, with Black and Hispanic patients being 30% to 50% more likely than whites to test positive for COVID-19. Researchers attribute this to several factors, including systemic health disparities, working frontline jobs and living in multigenerational households.
The team examined 303 active U.S. COVID-19 treatment trials involving more than 92,000 patients and used Census data from the 2015 American Community Survey to estimate the proportion of Black and Hispanic individuals who could be potentially recruited from the geographic catchment area of each study's recruitment hospital. This study did not include data on COVID-19 prevention studies, such as those testing vaccine candidates.
The researchers found the studies were being undertaken at hospitals that less frequently cared for Black and Hispanic patients: Only about 17% of these hospitals' patients were Black and 14% were Hispanic. There are several reasons why this may be happening, the researchers theorize.
"Smaller community hospitals may have larger communities of color but may not be equipped to set up these sorts of trials for infectious diseases," said Sukarn Chokkara, a second-year medical student at the University of Chicago Pritzker School of Medicine and lead author of the paper.
These same institutions may lack the experienced research staff and pharmaceutical company relationships needed to conduct clinical trials. Meanwhile, it can be burdensome for larger institutions designing clinical trials to implement study sites at smaller hospitals. Recruiting minority populations also frequently requires cultural tailoring and awareness of the legacy of discrimination and unethical medical research.
After conducting their cross-sectional analysis of non-observational COVID-19 clinical trials, the team also found that:
51% of trials excluded patients with non-severe comorbid diseases, such as diabetes.
About 60% of trials excluded pregnant women and/or required using contraception.
47% of trials excluded lactating women.
95% of trials excluded children less than 18 years old.
Medically complex patients, pregnant women, lactating women and children are routinely excluded from clinical trials because these groups are viewed as potentially complicating the work of researchers in understanding and evaluating a new treatment, along with concerns about the unknown long-term consequences of a treatment. These exclusions, however, lead to unintended consequences, Laiteerapong said.
"Given how little is known about COVID-19, being overly cautious with these populations means we have little evidence as to how to actually take care of them when they do contract SARS-CoV-2," she said.
One group that was sought out in COVID-19 treatment trials was older Americans: 86% of the studies included people over 85 years old.
The researchers say more inclusive studies are possible if the clinical trials community is diligent about recruiting populations not usually represented.
"Greater effort is needed to develop and study treatments in vulnerable populations, and this is going to take a long-term commitment to prioritize health equity," said Chokkara.
"Examining the inclusivity of US trials of COVID-19 treatment" was written by Sukarn Chokkara, Anna Volerman, Siddhi Ramesh and Neda Laiteerapong of the University of Chicago.
INFORMATION:
About the University of Chicago Medicine & Biological Sciences
The University of Chicago Medicine, with a history dating back to 1927, is one of the nation's leading academic health systems. It unites the missions of the University of Chicago Medical Center, Pritzker School of Medicine and the Biological Sciences Division. Twelve Nobel Prize winners in physiology or medicine have been affiliated with the University of Chicago Medicine. Its main Hyde Park campus is home to the Center for Care and Discovery, Bernard Mitchell Hospital, Comer Children's Hospital and the Duchossois Center for Advanced Medicine. It also has ambulatory facilities in Orland Park, South Loop and River East as well as affiliations and partnerships that create a regional network of care. UChicago Medicine offers a full range of specialty-care services for adults and children through more than 40 institutes and centers including an NCI-designated Comprehensive Cancer Center. Together with Harvey-based Ingalls Memorial, UChicago Medicine has 1,296 licensed beds, nearly 1,300 attending physicians, over 2,800 nurses and about 970 residents and fellows.
Visit UChicago Medicine's health and science news blog at http://www.uchicagomedicine.org/forefront.
ELSE PRESS RELEASES FROM THIS DATE:
2021-02-03
UPTON, NY - Hundreds of naturally occurring specialty fatty acids (building blocks of oils) have potential for use as raw materials for making lubricants, plastics, pharmaceuticals, and more--if they could be produced at large scale by crop plants. But attempts to put genes for making these specialty building blocks into crops have had the opposite effect: Seeds from plants with genes added to make specialty fatty acids accumulated dramatically less oil. No one knew why.
Now two teams of biochemists working on separate aspects of oil synthesis at the U.S. Department of Energy's Brookhaven National Laboratory have converged to discover the mechanism behind the oil-production slowdown. As described in the journal Plant Physiology, they crossbred model plants and conducted detailed ...
2021-02-03
TAMPA, Fla. -- The prognosis of ovarian cancer is poor, with an estimated five-year survival of only 40% for advanced disease, the stage at which most ovarian carcinomas are diagnosed. These poor outcomes are partly due to the lack of effective therapies for advanced disease and recurrence. Immunotherapies hold promise for many types of cancer; however, studies have shown that patients with ovarian cancer do not have strong responses to existing drugs. In a new article published in Nature, Moffitt Cancer Center researchers demonstrate why some ...
2021-02-03
There is an impassioned debate taking place in medicine on whether race-based considerations should be a factor in research, diagnoses, or treatments. Those on one side assert that race should be ignored entirely because it is a societal construct with no biological basis, and accordingly many hospitals are abandoning long-established "race corrections" in medical algorithms and diagnostics. Others, like Meghan McGarry, MD, MS, assistant professor of pediatrics at UC San Francisco, say that we can't completely ignore race, precisely because science is rarely free of societal influence - the structural inequality ...
2021-02-03
Since element 99 - einsteinium - was discovered in 1952 at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) from the debris of the first hydrogen bomb, scientists have performed very few experiments with it because it is so hard to create and is exceptionally radioactive. A team of Berkeley Lab chemists has overcome these obstacles to report the first study characterizing some of its properties, opening the door to a better understanding of the remaining transuranic elements of the actinide series.
Published in the journal Nature, the study, "Structural and Spectroscopic Characterization of an Einsteinium Complex," was co-led by Berkeley Lab scientist Rebecca Abergel and Los ...
2021-02-03
The Arctic Ocean was covered by up to 900 m thick shelf ice and was filled entirely with freshwater at least twice in the last 150,000 years. This surprising finding, reported in the latest issue of the journal Nature, is the result of long-term research by scientists from the Alfred Wegener Institute and the MARUM. With a detailed analysis of the composition of marine deposits, the scientists could demonstrate that the Arctic Ocean as well as the Nordic Seas did not contain sea-salt in at least two glacial periods. Instead, these oceans were filled with large amounts of freshwater under a thick ice shield. This water could then be released into the North Atlantic in very short periods of time. Such sudden freshwater inputs could explain rapid climate oscillations for which no satisfying ...
2021-02-03
What The Study Did: Data from the Centers for Disease Control and Prevention were used to look at changes in emergency department visits for mental health, suicide attempts, drug and opioid overdoses and outcomes of violence before and during the COVID-19 pandemic.
Authors: Kristin M. Holland, Ph.D., M.P.H., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(10.1001/jamapsychiatry.2020.4402)
Editor's Note: Please see the article for additional information, ...
2021-02-03
What The Study Did: COVID-19 outcomes including hospitalization and in-hospital death were compared between people living with or without diagnosed HIV in New York State.
Authors: Eli S. Rosenberg, Ph.D., of the State University of New York in Rensselaer, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2020.37069)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and ...
2021-02-03
Mechanism for control of antibiotic production in soil bacteria is visualised for the first time by scientists at University of Warwick and Monash University
Research reported in Nature could lead to improved manufacturing of existing antibiotics, and open up opportunities to discover new ones
The majority of clinically used antibiotics are derived from soil bacteria, but can be hard to find because their production is switched off in laboratory cultures
The discovery of how hormone-like molecules turn on antibiotic production in soil bacteria could unlock the untapped opportunities for medicines that are under our very feet.
An international team of scientists working at the University of Warwick, UK, and Monash ...
2021-02-03
ANN ARBOR, Mich. - The suicide rate among American adolescents has rose drastically over the last decade, but many at-risk youths aren't receiving the mental health services they need.
In fact, one of the greatest challenges is identifying the young people who need the most help.
Now, researchers have developed a personalized system to better detect suicidal youths. The novel, universal screening tool helps caregivers reliably predict an adolescent's suicide risk - alerting them to which ones need follow-up interventions - according to Michigan Medicine-led findings published in JAMA Psychiatry.
"Too many young people are dying by suicide and many at high risk go completely unrecognized and untreated," says lead author Cheryl King, Ph.D., ...
2021-02-03
CAMBRIDGE, MA -- Twenty years ago this month, the first draft of the human genome was publicly released. One of the major surprises that came from that project was the revelation that only 1.5 percent of the human genome consists of protein-coding genes.
Over the past two decades, it has become apparent that those noncoding stretches of DNA, originally thought to be "junk DNA," play critical roles in development and gene regulation. In a new study published today, a team of researchers from MIT has published the most comprehensive map yet of this noncoding DNA.
This map provides in-depth annotation of epigenomic marks -- modifications indicating which genes are turned on or off in different types of cells -- across 833 tissues and cell types, a significant increase over ...
LAST 30 PRESS RELEASES:
[Press-News.org] Most vulnerable often overlooked in clinical trials of new treatments for COVID-19
